Basics Quanterix Corporation Quanterix Corp is a life science company. The company digitizing biomarker analysis with the goal of advancing the science of precision health. IPO Date: December 7, 2017 Sector: Healthcare Industry: Biotech Market Cap: $356.4M Activated in VL: True Average Daily Range Avg Daily Range: $0.74 | 3.08% Avg Daily Range (30 D): $0.21 | 3.56% Avg Daily Range (90 D): $0.16 | 2.85% Institutional Daily Volume Avg Daily Volume: .3M Avg Daily Volume (30 D): .7M Avg Daily Volume (90 D): .59M Trade Size Avg Trade Size (Sh.): 70 Avg Trade Size (Sh.) (30 D): 79 Avg Trade Size (Sh.) (90 D): 80 Institutional Trades Total Inst.Trades: 1,281 Avg Inst. Trade: $1.32M Avg Inst. Trade (30 D): $.54M Avg Inst. Trade (90 D): $.7M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.26M Avg Closing Trade (30 D): $.61M Avg Closing Trade (90 D): $.86M Avg Closing Volume: 46.83K     News May 23, 2025 @ 1:10 PM New Data and Deal Flow Signal a Turning Point for ... Source: Prnewswire Apr 28, 2025 @ 10:00 PM $HAREHOLDER ALERT: The M&A Class Action Firm Urges... Source: Monteverde & Associates Pc Apr 2, 2025 @ 10:50 PM $TOCKHOLDER ALERT: The M&A Class Action Firm Urges... Source: Monteverde & Associates Pc Feb 18, 2025 @ 8:30 PM Quanterix Corporation Announcement: If You Have Su... Source: N/A Feb 14, 2025 @ 11:30 PM $TOCKHOLDER ALERT: The M&A Class Action Firm Conti... Source: Monteverde & Associates Pc Financials   TTM Q3 2025 Q2 2025 Basic EPS $-2.33 $-.73 $-.77 Diluted EPS $-2.33 $-.73 $-.77 Revenue $ 130.2M $ 40.23M $ 24.48M Gross Profit $ 67.09M $ 17.21M $ 11.3M Net Income / Loss $ -95.66M $ -33.52M $ -30.01M Operating Income / Loss $ -115.56M $ -37.33M $ -37.1M Cost of Revenue $ 63.11M $ 23.03M $ 13.18M Net Cash Flow $ 9.69M $ -93.9M $ 56.39M PE Ratio